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Abstract 
 
Treatment of acute lymphoblastic leukemia (ALL) has been promising in last decades, but side effects still 
persist and searching for the least toxic agents continue. Pterostilbene (PTE) is a natural compound with 
several anti-cancer and anti-oxidant properties. Fas, as a member of death inducing family of tumor necrosis 
factor (TNF) receptors with an intracellular death domain, can initiate the extrinsic apoptosis signaling 
pathway. Here after the half maximal inhibitory concentration (IC50) determination in cell lines, we searched 
for PTE effects on Fas, both in mRNA and surface levels in two ALL cell lines, Jurkat and Molt-4. After 
harvesting cells in optimum situations, MTS assay was used to determine IC50 concentrations. Real-time 
polymerase chain reaction (RT-PCR) and flow cytometry were performed for Fas mRNA and surface 
expression variations after exposure to PTE. The findings showed that PTE decreases cell viability with 
different extent in two ALL cell lines. In addition to inducing apoptosis, it can increase Fas in both gene and 
cell surface expression in the same concentrations. Pterostilbene as a natural anti-cancer agent can increase 
Fas expression both in mRNA and surface levels that results in apoptosis signal transduction improvement 
which sensitizes cells to apoptosis by immune effector cells. As a result, abnormal cells removal would be 
more efficiently with the minimum side effects on normal cells. 
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INTRODUCTION 
 
Acute lymphoblastic leukemia (ALL) is the 
malignancy of hematopoietic ancestor stem 
cells that occurs in both children and adults but 
its prevalence is around 2 to 5 years old 
(1).The main character of ALL is influx of 
immature lymphocytes from bone marrow to 
blood stream and other peripheral organs (2). 
It comprises 25% of cancers happening before 
the age of 15 years and 19% among those 
younger than 20 years (3). Usual treatment 
methods are chemotherapy and radiotherapy 
that are not always completely efficient and 
have many side effects (4). Bone marrow 
transplantation is another treatment approach, 
but has only really remarkable outcome in up 
to 40% in average (5). Today, cancer scientists 
are looking for natural anti-oxidants which are 
less harmful. Among several candidates, 
stilbenes which are naturally found in 
blueberries and grapes have attracted lots of 
research interest. The best known stilbenes are 
resveratrol (RES) and pterostilbene (PTE) (6). 
Resveratrol (trans-3,5,4 V–trihydroxystilbene), 
is a phytoalexin in grapes especially red grapes 
that shows a variety of pharmacological 
properties like cancer and inflammation 
prevention, cell cycle arrest and apoptosis 
induction.  
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It has three hydroxyl groups which 
decreases its bioavailability in oral 
prescription and faces concerns in clinical uses 
(7). Pterostilbene (trans-3, 5- dimethoxy- 4- 
hydroxy stilbene) is a natural dimethylated 
analog of RES that is primarily found in 
blueberries and proposes anticancer, anti-
inflammation, anti-oxidant, apoptosis 
induction, and anti-proliferation features (8). 
Structural differences of PTE, which make it 
different from RES are two methoxy and one 
hydroxyl groups that leads to its better 
bioavailability (9). Additional to absorption 
improvement, some studies have demonstrated 
that PTE may have greater antioxidant and 
anticancer effects than RES. 
All of these resulted in introduction of PTE 
as a potential anticancer drug in clinical uses. 
Some researchers have shown that PTE can 
induce anti-proliferative and apoptosis 
induction effects on solid tumors such as lung 
cancer (10) as well as liquid malignancies such 
as chronic myelogenous leukemia and 
lymphoblastic leukemia (11). The exact 
mechanism especially on leukemic cells has 
not been explained yet. 
Apoptosis is a form of programmed cell 
elimination, which is classified as type I 
morphological cell death in multicellular 
organisms and has the main role in embryonic 
development, proliferation control, and auto 
reactive lymphocyte removing (12). As an 
advantage, compared to the other cell death 
types such as necrosis, apoptotic cell removal 
occurs with no immune response to apoptotic 
cell antigens and neighboring tissue damaging 
(13). According to the signal initiators, there 
are two main apoptosis pathways: intrinsic and 
extrinsic. In extrinsic or cytoplasmic way, 
following apoptotic ligands binding to death 
receptors from tumor necrosis factor receptor 
(TNFR) family, such as CD95 (APO-1/Fas) 
and TRAIL receptors, signals will be activated 
(14). Today we know that while Fas ligand 
(FasL) expression is limited to cytotoxic T 
cells, natural killer cells, and immune privilege 
tissues, Fas can be found on almost all cells 
(15). After binding to FasL or mAbs, Fas 
homo-trimerization occurs and conformation 
changes make it ready for signaling 
transduction which proceed to death complex 
formation and eventually make DNA 
fragmented and causes cell death (16).  
According to the above mechanism, using 
methods that enhance Fas expression at both 
gene and surface levels in leukemic cells will 
improve apoptosis induction and efficient 
clearance by immune cells from blood. In this 
study we examined the PTE effects on Fas 
mRNA level and its surface appearance on 
Jurkat and Molt-4 lymphoblastic cells. 
 
MATERIALS AND METHODS 
 
Cell culture 
Jurkat (C121) and Molt-4 lymphoblastic 
cell lines were purchased from Pasteur 
Institute of Iran, I.R. Iran, and were cultured in 
RPMI 1640 medium (GibcoR, USA) 
supplemented with 10% fetal bovine serum 
(FBS),100 U/mL penicillin, and 100 mg/mL 
streptomycin. Cells were maintained in cell 
culture flasks under standard cell culture 
conditions (humidified atmosphere of 5% CO2, 
in 37 °C incubator) and were passaged every 
2-3 days (17). The cells were stained with 
trypan blue and counted on a hemocytometer 
to evaluate the number of live and dead 
neoplastic cells. 
 
In vitro cytotoxicity assay 
Cells were seeded at 104 cells/well in 96-
well microtiter plates and treated with various 
concentrations (0, 20, 40, 60, 80, 100, 120, 
140, 160, and 180 µM) of PTE for 24, 48, and 
72 h to evaluate IC50s in the presence of PTE. 
Pterostilbene was purchased from Sigma-
Aldrich, Germany. Stock solution was 
prepared in dimethyl sulfoxide (DMSO), 
stored at -20 °C and diluted with culture 
medium prior to the experiment. Each test was 
carried out 3 times. Afterward, the cytotoxic 
effects of the PTE on cell viability were 
assessed using MTS assay (17). Solubilized 
formazan absorbance was read at 490 nm 
using an ELISA reader (Stat Fax 3200, 
Awareness Technology, USA).  
 
Real-time polymerase chain reaction  
About 2 × 105 cells from each line were 
treated with different concentrations of PTE  
in 6-well plates for 24, 48, and 72 h.  
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Table 1. GAPDH and Fas primer sequences.  
Gene Sequences Product TM 
GAPDH Forward: 5′‑ACACCCACTCCTCCACCTTTG‑3
/ 
Reverse: 5′‑CCACCACCCTGTTGCTGTAG‑3/ 129 60 
Fas Forward: 5′-TGAAGGACATGGCTTAGAAGTG-3′ Reverse: 5′- GGTGCAAGGGTCACAGTGTT-3′ 118 60 
 
Total RNA was extracted using RNX reagent 
according to the manufacturer’s instructions. 
The total RNA concentrations were measured 
by 260/280 nm absorbance ratio using 
NanoDrop spectrophotometer (Thermo, USA). 
Complementary DNA (cDNA) was prepared 
from RNA using a synthesis kit (Takara Bio 
Inc., Japan) using 1μg total RNA according to 
the manufacturer’s instructions.  
The procedure of cDNA reverse transcription 
was carried out using Prime Script reagent kit 
(Takara Bio Inc .Japan). Cycles were 
performed as heat denaturation 3 min at 60 °C, 
annealing with oligo (dT) primers for 45 min 
at 42 °C and reactions were stopped by heat 
inactivation for 5 min at 90 °C. Later, aliquots 
of 10 µL of cDNA were amplified by real-time 
polymerase chain reaction (RT-PCR using 
SYBR green PCR master mix (Qiagen, 
Germany) in the presence of specific primers 
for Fas (18). 
The primers were designed using                  
Oligo 6.0 (Molecular Biology Insights, 
Cascade, CO, USA) and confirmed by the 
blast (NCBI), Table 1. They were purchased 
from Eurogentec (Seraing, Belgium). Fas gene 
expression was detected using Rotor-Gene 
3000 (Corbett, Australia) for each mentioned 
concentration.  
The temperature profile for the reaction was 
an initial denaturation stage of 95 °C at               
10 min, then a three-step program was 
developed for 40 cycles including 95 °C for  
15 sec, 61 °C for 25 sec, and 72 °C for 30 sec 
respectively. A housekeeping gene, GAPDH, 
was quantified as an endogenous control gene 
for the normalization of Fas expression.  
 
Flowcytometric analysis 
For investigating the effects of PTE on 
surface Fas expression, 2 × 105 cells from each 
cell lines were seeded in each well of 6-well 
plate and after incubation with different 
concentrations of PTE (0, 20, 40, 60, 80 µM 
for Jurkat and 0, 120, 140, 160, 180 µM for 
Molt-4 cells) for 48 h, they were prepared for 
flowcytometry analysis. For each cell line, the 
tests were done 3 times. After washing twice 
with phosphate buffered saline (PBS),                  
106 cells of each concentration was re-
suspended in 1 mL ice-cold PBS.  
Fluorescein isothiocyanate (FITC)-
conjugated F(ab')2 fragments of Fas anti-
human mouse IgG MoAb (ABclonal USA) 
were used to determine the expression of 
surface Fas in Jurkat and Molt-4 cells with and 
without PTE treatment (18).  
 
Statistical analysis 
Quantitative data were reported as the mean 
± SD for the individual experiments.                  
Data were analyzed on SPSS and graphs               
were traced with the program GraphPad    
Prism. Statistical analysis was done              
using the Student's t-test and P values below 
0.05 were considered statistically significant. 
RT-PCR data were analyzed by Livak method 
and IC50 values were calculated with                
probit analysis. 
 
RESULTS 
 
Effect of pterostilbene on cell viability 
As shown in Fig. 1, cell proliferation has 
been affected by PTE treatment in a dose-
dependent manner after each treatment             
period.   
The IC50 values for Molt-4 cell line were 
found to be 46.92 ± 2.15, 126.9 ± 3.21, and 
63.32 ± 2.45 µM after 24, 48, and 72 h 
exposure to PTE, respectively. We confirmed 
our previous data on Jurkat cells and PTE 
displayed an IC50 of 67.78 ± 3.88, 60.97 ± 
3.36, and 52.11 ± 2.50 µM after 24, 48 and            
72 h incubation, respectively (17). The results 
indicate that PTE can potently inhibit 
proliferation of Molt-4 and Jurkat leukemic 
cell lines.  
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Fig.1. (A), Jurkat and (B), Molt-4 cells were treated with different concentrations of PTE for indicated periods. The 
experiments have been repeated at least 3 times for all used concentrations. For each indicated time point, cell viability 
decreased in a dose-dependent manner, but has instability at 24 h for Molt-4 cells. 
 
Effect of pterostilbene on Fas mRNA 
expression levels 
Fas expresses on almost all cell types but its 
frequency is decreased on the surface of 
leukemic cells to escape from immune 
responses. Real-time polymerase chain 
reaction was used to determine PTE effects on 
Fas mRNA levels (Fig. 2). The expression of 
GAPDH and Fas were determined in the same 
reaction system. Fas was expressed in base 
line level in cells but treatment with PTE 
increased its frequency in to a significant level 
at 40 µM after 24 and 48 h and 80 µM after  
72 h treatment in Jurkat cells and 40 µM after 
24 and 72 h and 180 µM after 48 h treatment 
in Molt-4 cells. In Jurkat cells the expression 
was more than 6 times at 20 and 60 µM and 
about 8 times at 80 µM concentration of PTE 
after 48 h treatment. However in Molt-4 cells 
the expression was more than 20 times of 
control at 180 µM concentration after 48 h 
treatment, but the most increase at 24 and 72 h 
incubation was about 2 and 5 times of control 
that occurred at 40 µM concentration.  
 
Effect of pterostilbene on surface Fas 
expression  
Surface analysis of Fas expression was 
performed after 48 h incubation with PTE 
using flow cytometry. As Fas mRNA had the 
highest expression at 48 h (Fig. 2), this time 
point was considered for further study of the 
surface expression. Mean fluorescent intensity 
of stained cells was compared to that of the 
control. As shown in Fig. 3A-3F, in Jurkat 
cells the highest expression was observed at           
40 µM which declined again with increasing 
the PET concentration, however, in Molt-4 
cells all concentrations of PTE increased 
surface Fas expression compared to control 
with the highest increase at 180 µM 
concentration (Fig. 3G-3L).  
A 
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Fig. 2. Fas mRNA expression after 3 different treatment periods with pterostilbene (PTE). (A-C), demonstrate 
expression in 24, 48, and 72 h respectively for Jurkat cells. The maximum gene expression increase was observed at 40 
µM concentration after 48 h treatment. In Molt-4 cells (E), the maximum gene expression increase was at 180 µM after 
48 h treatment but (D and F) in 40 µM concentration after 24 and 72 h incubation time. * shows significant difference 
with control (P < 0.05). 
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Fig. 3. Flowcytometric analysis of surface Fas expression. Cells treated for 48 h with pterostilbene (PTE) or left 
untreated and then stained with anti-CD95 (Fas) monoclonal antibody according to manufacturer instruction. Parts A-F 
are examples of flow cytometric analyasis of treated jurkat cells with 0, 20 ,40, 60 and 80 µM concentration of PTE 
respectively and graph M compares mean fluorescent intensity (MFI) of Fas expression in the presence of above 
concentrations. All used concentrations increased surface Fas expression with the maximum increase at 40 µM 
concentration (more than 2 times of control). Parts G-L are examples of flow cytometric analyasis of treated Molt-4 
cells with 0, 120 ,140, 160 and 180 µM concentration of PTE respectively and graph N compares MFI of Fas 
expression in the presence of above concentrations. Treatment with PTE increased the levels of Fas expression in           
Molt-4 with the maximum increase in 180 µM concentration. * shows significant difference compared to control group 
(P < 0.05). 
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DISCUSSION 
 
A usual treatment method for ALL like 
other cancers is chemo and radiotherapy. 
Although treatment procedures of ALL have 
promoted over the last four decades and 
caused survival of almost 80%, the main issue 
is reducing treatment-related side effects, 
which is observed in more than two thirds of 
survivors (19). Side effects that can affect 
patients life quality even after complete 
recovery of disease as the main limitation of 
usual methods from one side and cancer rate 
growth worldwide from another side, have 
encouraged searching for new safe and more 
efficient treatments. Resistance to apoptosis is 
the main mechanism by which cancer cells 
maintain in body fluids and tissues. Today, 
herbal products with apoptosis induction 
ability have become a great point of view in 
anti-cancer agent development. Pterostilbene 
can be viewed as a well-known therapeutic 
polyphenol and despite the fact that its 
principal mechanism is not still completely 
clear, it can interfere in multiple signaling 
pathways that are necessary for cancer 
development. In this study, we first focused on 
PTE IC50s after three time periods that induces 
cell death in lymphoblast cell lines. Values of 
72- h IC50 was lower than that of 48-h ones, as 
it has been reported for other plants-derived 
extracts on leukemia cells (20). Remsberg            
et al. introduced PTE as a significant anti-
inflammatory, antioxidant, antitumor, and 
analgesic factor. They demonstrated that              
65 µM concentration of PTE for 24 h could 
inhibit the cell growth of MCF-7 breast cancer 
up to 50% (21). This finding is similar to our 
data for jurkat but not for Molt-4 cells. 
Suppression of cell proliferation and G0/G1 
cell cycle arrest has been reported in myeloid 
cell lines upon treatment with PTE. The 
induction of cell apoptosis has been found 
through mithochondrial dependent pathway (22). 
Tolomeo et al. reported that this 
dimethylated stilbene is an apoptotic-inducing 
operative in various leukemia cells, which are 
resistant to apoptosis induced by several 
anticancer agents and PTE toxicity on normal 
blood progenitor cells was less than                          
on leukemia and lymphoma cells (23). 
Pterostilbene exhibited the highest 
bioavailability of about 80% among 
stilbenoids. Two methoxy groups in the PTE 
structure make it more lipophilic and thus 
more bioavailable than RES (8). Pterostilbene 
is also known to be more metabolically stable 
because of its free hydroxyl group (24). As 
PTE has higher lipophilicity, it causes more 
powerful inhibitory effect on some cancer cells 
than RES (25). We found that PTE IC50 on 
Molt-4 cells was 126.9 µM after 48 h. 
Considering 48 h IC50, our results also indicate 
that Molt-4 cells are more resistant to PTE 
compared to Jurkat cells. This type of 
resistance for Molt-4 cells has also been 
demonstrated in a study that resulted in 
unefficient effect of algal extract on Molt-4 
cells compared to Jurkat cells (26). As we 
know cancer treatment and its complete uproot 
relies on malignant cell removal from body 
which means their death without any harm for 
normal cells, so understanding different kinds 
of cell death in detail, will yield a molecular 
basis for new treatment strategies targeting 
these mechanisms in all forms of cancer 
including resistant types (27). Pan et al. 
showed that in human gastric adenocarcinoma 
cell lines, PTE activates caspase cascade via 
both mitochondrial and Fas/FasL pathways. 
Growth inhibitory effects and apoptosis 
induction on gastric cancer cells arrest them in 
the G0/G1 phase (28). Treatment of HL-60 
cells by PTE at IC90 resulted in G0/G1 cell 
cycle arrest (29). Roslie et al. have reported 
phosphatidyl serine externalization and loss of 
mitochondrial integrity in K562 leukemia cell 
line. They also found early caspase                  
9 activation in these cells (30). These data 
confirmed the variation of PTE effects 
depending on the cancer types and sites and 
improved it as a useful drug alone or along 
with other cancer therapy methods. 
Furthermore, administration of PTE at a dose 
of 125 mg twice daily for 6-8 weeks was 
found to be safe and did not induce any 
significant adverse reactions (31). As 
reduction in Fas expression has been known as 
an immune escape mechanism by malignant 
cells, restoration and improvement of Fas 
expression has been studied in several 
researches. We have previously reported 
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induction of apoptosis and enhancement                   
of caspase-3 after PTE treatment in 
lymphoblastic leukemia cell line (under 
review). Here we also investigated PTE effects 
on Fas expression both at gene and surface 
levels that resulted in introducing the 
appropriate concentrations of PTE for Fas 
expression on both cell lines. As the gene 
expression may not necessarily result in 
protein expression, the surface Fas was also 
studied. Such effects have already been 
reported by other plants-derived component in 
lymphoblastic leukemia cells (32). 
Pterostilbene also induces apoptosis through 
the caspase-independent pathway in both 
sensitive and chemo-resistant lymphoid 
leukemia cell lines (33). Gulbins showed that 
cytotoxic drugs enhance Fas gene transcription 
as well as surface expression improvement. 
Also it has been shown that anticancer agents 
increase Fas receptor by enhancing Fas gene 
expression in tumor cells (34). Our data 
demonstrated that the Fas gene and surface 
protein expression have the same pattern in 
both cell lines.  
 
CONCLUSION 
 
In conclusion, we focused on PTE effects 
on Fas as one of the fundamental apoptosis 
signaling initiators, expressed on the surface of 
various mammalian cell types and essential for 
extrinsic pathway activation. For the first time, 
we also found that PTE can induce Fas surface 
and mRNA expression in a same concentration 
in both cell lines, which can be considered an 
advantage in PTE administration and is 
necessary before PTE can be considered for 
cancer treatment in vivo. Our findings also 
suggest that PTE-induced apoptosis in 
lymphoblastic cells may be dependent on 
extrinsic pathway. More detailed experiments 
at the molecular level and downstream signaling 
pathways can help to more comprehensive 
understanding of the involved mechanisms.  
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